+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Sacral Nerve Stimulation Market Report and Forecast 2023-2031

  • PDF Icon


  • 147 Pages
  • April 2023
  • Region: Global
  • Expert Market Research
  • ID: 5786921
Global Sacral Nerve Stimulation Market Report and Forecast 2023-2031
Global Sacral Nerve Stimulation Market Outlook
The value of the global sacral nerve stimulation market was USD 1210.25 million in 2022, driven by the by increasing prevalence of urinary and faecal incontinence across the globe across the globe. The market is expected to grow at a CAGR of 12.50% during the forecast period of 2023-2031 to reach value of USD 3493.41 million by 2031.

Sacral Nerve Stimulation: Introduction

Sacral nerve stimulation (SNS) is a medical procedure that uses electrical impulses to stimulate the sacral nerves, which are located at the base of the spinal cord. This treatment is used to treat a variety of conditions such as urinary and faecal incontinence, chronic pelvic pain, and other lower urinary tract symptoms. SNS involves the implantation of a small device, which is placed under the skin near the buttocks and connected to a thin wire that runs to the sacral nerves. The device delivers electrical impulses that help regulate the function of the bladder and other pelvic organs. SNS is considered a minimally invasive procedure and can be an effective alternative for patients who have not responded to other treatments.

Sacral Nerve Stimulation: Application and Uses

Sacral nerve stimulation (SNS) is a medical treatment used to manage several conditions, including urinary and faecal incontinence, pelvic pain, and constipation. The treatment involves implanting a small device under the skin near the sacral nerve in the lower back. This device sends electrical impulses to the sacral nerve, which helps to regulate bladder and bowel function and reduces pelvic pain.

SNS is primarily used for the treatment of urinary and faecal incontinence. In patients with urinary incontinence, SNS can improve bladder control by decreasing detrusor overactivity and increasing bladder capacity. In patients with faecal incontinence, SNS can improve anal sphincter function and reduce episodes of faecal leakage. SNS has also been used to treat chronic pelvic pain and constipation in certain patient populations.

Global Sacral Nerve Stimulation Market Segmentations

Market Breakup by Product

  • Implantable SNS Devices
  • External SNS Devices

Market Breakup by Type

  • Electrical Muscle Stimulation
  • Transcutaneous Electrical Nerve Stimulation

Market Breakup by Application

  • Urinary and Faecal Incontinence
  • Urge Incontinence
  • Chronic Anal Fissure
  • Others

Market Breakup by End User

  • Hospitals
  • Ambulatory Surgical Centres
  • Others

Market Breakup by Region

North America

  • United States of America
  • Canada


  • United Kingdom
  • Germany
  • France
  • Italy
  • Others

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • Others

Latin America

  • Brazil
  • Argentina
  • Mexico
  • Others

Middle East and Africa

  • Saudi Arabia
  • United Arab Emirates
  • Nigeria
  • South Africa
  • Others

Global Sacral Nerve Stimulation Market Scenario

The global market for sacral nerve stimulation is expected to grow due to the increasing prevalence of urinary and faecal incontinence and the rising demand for minimally invasive procedures. The market is also driven by technological advancements, favourable reimbursement policies, and the growing awareness of the benefits of sacral nerve stimulation. The market is segmented by product type, application, end-user, and geography. The major players in the market include Medtronic, Boston Scientific, and Axonics Modulation Technologies.

Key Players in the Global Sacral Nerve Stimulation Market

The report gives an in-depth analysis of the key players involved in the global sacral nerve stimulation market. The companies included in the market are as follows:
  • Medtronic
  • Abbott Laboratories
  • Axonics, Inc
  • Boston Scientific Corporation
  • St. Jude Medical
  • Cyberonics
  • Neuropace
  • Synapse Biomedical
  • Uroplasty Inc
  • Codman And Shurtleff Inc
  • IntraPace Inc

This product will be delivered within 5-7 business days.

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Sacral Nerve Stimulation Market Overview
3.1 Global Sacral Nerve Stimulation Market Historical Value (2016-2022)
3.2 Global Sacral Nerve Stimulation Market Forecast Value (2023-2031)
4 Global Sacral Nerve Stimulation Market Landscape
4.1 Global Sacral Nerve Stimulation Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Sacral Nerve Stimulation Product Landscape
4.2.1 Analysis by Type of Biosensor
4.2.2 Analysis by Technology Used
4.2.3 Analysis by Applications
5 Global Sacral Nerve Stimulation Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Sacral Nerve Stimulation Market Segmentation
6.1 Global Sacral Nerve Stimulation Market by Product
6.1.1 Market Overview
6.1.2 Implantable SNS Devices
6.1.3 External SNS Devices
6.2 Global Sacral Nerve Stimulation Market by Type
6.2.1 Market Overview
6.2.2 Electrical Muscle Stimulation
6.2.3 Transcutaneous Electrical Nerve Stimulation
6.3 Global Sacral Nerve Stimulation Market by Application
6.3.1 Market Overview
6.3.2 Urinary & Fecal Incontinence
6.3.3 Urge Incontinence
6.3.4 Chronic Anal Fissure
6.3.5 Others
6.4 Global Sacral Nerve Stimulation Market by End User
6.4.1 Market Overview
6.4.2 Hospitals
6.4.3 Ambulatory Surgical Centres
6.4.4 Others
6.5 Global Sacral Nerve Stimulation Market by Region
6.5.1 Market Overview
6.5.2 North America
6.5.3 Europe
6.5.4 Asia Pacific
6.5.5 Latin America
6.5.6 Middle East and Africa
7 North America Sacral Nerve Stimulation Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Sacral Nerve Stimulation Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Sacral Nerve Stimulation Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.6 Australia
9.7 Others
10 Latin America Sacral Nerve Stimulation Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Sacral Nerve Stimulation Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.5 Others
17 Supplier Landscape
17.1 Medtronic
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Abbott Laboratories
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Axonics, Inc.
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Boston Scientific Corporation
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 St. Jude Medical
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Cyberonics
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Neuropace
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Synapse Biomedical
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Uroplasty Inc.
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Codman And Shurtleff Inc.
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 IntraPace Inc.
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
18 Global Sacral Nerve Stimulation Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket

Companies Mentioned

  • Medtronic
  • Abbott Laboratories
  • Axonics, Inc.
  • Boston Scientific Corporation
  • St. Jude Medical
  • Cyberonics
  • Neuropace
  • Synapse Biomedical
  • Uroplasty Inc.
  • Codman and Shurtleff Inc.
  • Intrapace Inc.



Table Information